Mealey's (July 30, 2018, 1:42 PM EDT) -- CHICAGO — Health insurer Medical Mutual of Ohio (MMO) on July 27 was ordered to provide specific answers to testosterone replacement therapy drug makers relating to when the insurer told employees to hold discovery related data in litigation involving alleged wrongful promotion of testosterone therapy drugs (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, Medical Mutual of Ohio v. AbbVie, Inc., No. 14-8857, N.D. Ill., Eastern Div.)....